Community insights into type 1 diabetes care in Armenia: a qualitative study informing health policy reform Authors: Alec Ohanian, Varak Ghazarian, Karine Mkhitaryan, Elena Aghajanova, Lorky Libaridian, Roza Selimyan Published: 2026 ABSTRACT AbstractObjectivesTo explore the lived experiences of children with type 1 diabetes (T1D) and their caregivers in Armenia, a post-Soviet country, and to identify system-level barriers to care from the community perspective.DesignQualitative study using a phenomenological design with inductive thematic analysis.SettingMuratsan Hospital Complex, the primary national referral centre for paediatric endocrinology, Yerevan, Armenia.Participants12 children aged 13–17 years with T1D and their caregivers, recruited through purposive sampling across 7 of Armenia’s 10 administrative regions.ResultsFive themes emerged from the data: (1) barriers to care, (2) quality of care, (3) perceived control of T1D, (4) knowledge of T1D and (5) government and non-governmental organisation (NGO) support. Participants described unreliable government-supplied glucose strips, geographical barriers rooted in the centralisation of specialist care in the capital, abrupt withdrawal of state support at age 18, reliance on the KATIL NGO to fill gaps in both clinical and psychosocial support and pervasive stigma encountered across family, school and clinical settings.ConclusionsChildren with T1D in Armenia navigate a post-Soviet health system where provisions exist but remain fragmented, limited by centralised care, geographical barriers and variable support. This unique context shapes the relationship and expectations patients have of the healthcare system. Community perspectives are indispensable in these settings, surfacing system-level gaps that conventional data cannot capture. These findings have relevance for other health systems navigating similar structural transitions. STRENGTHS AND LIMITATIONS OF THIS STUDY Purposive sampling achieved geographical representation across seven of Armenia’s 10 administrative regions, strengthening the diversity of perspectives captured. Purposive sampling achieved geographical representation across seven of Armenia’s 10 administrative regions, strengthening the diversity of perspectives captured. Interviews and inter-rater reliability were conducted in an anonymised format by study members who were not affiliated with either Muratsan or KATIL, reducing institutional bias. Interviews and inter-rater reliability were conducted in an anonymised format by study members who were not affiliated with either Muratsan or KATIL, reducing institutional bias. Recruitment through Muratsan and KATIL may have introduced a selection bias as participants likely had greater access to care and may have answered more favourably. Recruitment through Muratsan and KATIL may have introduced a selection bias as participants likely had greater access to care and may have answered more favourably. The study focused on children aged 13–17 years registered at a single national referral centre, limiting generalisability to younger children, adults and those outside the formal care system. The study focused on children aged 13–17 years registered at a single national referral centre, limiting generalisability to younger children, adults and those outside the formal care system. Background Type 1 diabetes (T1D) is an insulin-dependent form of diabetes that occurs due to autoimmune destruction of pancreatic beta cells, requiring lifelong insulin replacement.1 The chronicity and lifelong exposure results in large reductions in life expectancy, ranging from 10 years in HMICs (high-middle-income countries) to 17 years in LMICs (low- and middle-income countries).25 LMICs face multiple challenges that exacerbate this inequity such as inconsistent insulin supply, poor monitoring systems, limited specialty care, socioeconomic barriers and poor public awareness that leads to stigma, delayed diagnosis and worse complications.68 Armenia is a recently transitioned upper-middle-income country of interest as it had a diabetes age-adjusted death rate of 13.5 per 100 000 in 2023 which is elevated when compared with other post-Soviet countries.9 Like many post-Soviet states, Armenia’s healthcare system remains influenced by the Semashko model, which is a centralised healthcare system that includes state-funded care, concentration of specialised services and a ‘dispensary’ approach to chronic disease management. While this model attempted to provide universal access, the evolution of healthcare and primary care has often resulted in fragmented care delivery, uneven resource distribution and limited adaptability to chronic disease management such as T1D.10 Post-Soviet countries therefore face distinct structural challenges compared with other LMICs, making the Armenian experience particularly relevant beyond its national context. According to the most recent formal epidemiological study from 2014, among the paediatric population (0–17 years old) in Armenia, the annual incidence rate of T1D was 9.08 per 100 000 and the prevalence of T1D was 53.3 per 100 000.11 More recent estimates from partners in the field suggest an incidence rate of 8.83 per 100 000 per year and a prevalence of 122.66 per 100 000 (E Aghajanova, personal communication, 2025).12 The most recent assessment of diabetes care in13 Armenia, a 2012 rapid appraisal by the American University of Armenia, identified expensive consumables, high social stigma and poor institutional coordination as key barriers.13 This report was not specific to the type of diabetes, excluded patients ≤18 years old and is over a decade old. Therefore, there is an information gap with regards to the current experience, needs and barriers of diabetes care for individuals with T1D. Qualitative studies have begun to address similar gaps in other LMICs, identifying shared barriers including stigma, long travel distances and limited provider expertise, with non-governmental organisations (NGOs) and family support emerging as critical systems of support.71417 This study expands on that literature by focusing on the community experience in Armenia, using it as a lens to identify system-level gaps and generate policy insights applicable to post-Soviet health systems facing similar structural challenges. Methods Setting The Muratsan Hospital Complex (Muratsan) in Yerevan serves as the primary endocrinology centre in the country. Therefore, almost all children under the age of 18 with T1D are registered at Muratsan. At the time of the study this amounted to approximately 770 patients. Other centres include the Austrian Children’s Hospital of Gyumri in the Shirak province where approximately 50 children were registered, and the Arabkir Medical Center where roughly 10 children were registered. Additionally, since 2012, the KATIL Charitable Foundation, an NGO based in Armenia, has been providing social services for children with T1D. Study design and participants This study used a phenomenological qualitative design guided by an interpretivist paradigm. Inductive thematic analysis was applied to explore how children and caregivers experience T1D care in Armenia. Purposive sampling was used to recruit participants with the intention of interviewing 10–25 participants to saturation. The target participant count considered prior studies and the intended 1-hour length of interviews.7 14 15 The inclusion criteria were as follows: (1) children aged 13–17 years old diagnosed with T1D, (2) diagnosis of T1D before 1 October 2022 and (3) registered at Muratsan. Data collection Paediatric endocrinologists at Muratsan and staff at KATIL who had access to patient information through existing agreements with Muratsan assisted in the identification of participants. Semi-structured interviews were conducted in January 2023. A standardised semi-structured interview guide was developed using scripts from prior studies and adapted to the Armenian context in collaboration with local teams (online supplemental appendix 1).7 14 15 Interviews were conducted in an anonymised format by study members who were not affiliated with either Muratsan or KATIL. Interviews were conducted in-person in Armenian, audio-recorded and transcribed verbatim with an accompanying English translation. Data analysis Textual data were analysed using thematic analysis in an open-ended approach to allow codes and themes to emerge from the data. Descriptive analysis was used to limit subjectivity. Two coauthors (AO and VG) who were not affiliated with Muratsan or KATIL independently reviewed and coded the transcripts, then cross-validated their coding inputs to ensure consistency in their interpretations and establish inter-rater reliability. Discrepancies were reviewed by both coders and resolved with discussion. Deviant cases were highlighted in the analysis to ensure all viewpoints were represented. Data triangulation was strengthened by coauthors representing both civil society and government perspectives in diabetes care who helped with contextual accuracy. Data management and analysis were facilitated using the Johns Hopkins Bloomberg School of Public Health OneDrive and NVivo qualitative data analysis software. NVivo was used to organise codes, support cross-validation between coders and visualise thematic relationships across the dataset. The resulting code hierarchy tree map is illustrated in figure 1. NVivo tree map illustrating the hierarchical coding structure. Box size reflects relative coding density within each theme and subcode. NGO, non-governmental organisation. Patient and public involvement Patients were involved with this study from its inception. The priorities they voiced to our partners in the field shaped the research questions and the interview guide. They were not involved in selecting outcome measures or recruitment. We plan to partner with patients who have shown interest in distributing the findings among their communities. SRQR reporting This study was reported in accordance with the Standards for Reporting Qualitative Research (SRQR) guideline, and the corresponding checklist is included as online supplemental A.18 Results In-depth interviews were conducted with one caregiver, four children and seven children with their caregivers. All 12 patients were 13–17 years old and registered at Muratsan. There was representation from multiple administrative regions including Artsakh (Nagorno-Karabakh), Yerevan, and 6/10 provinces in Armenia (Ararat, Armavir, Vayots Dzor, Shirak, Tavush and Syunik) (figure 2). Participants were predominantly female (9/12). The median time since diagnosis was 6.67 years and the median age of participants was 16 years old. Mean glycated haemoglobin (HbA1c) values were 7.96%±1.427. Most participants received support from KATIL (9/12) (table 1). Geographical distribution of participants on map of Armenia. Table 1Descriptive characteristics of participants in qualitative interviews (n=12)Participant characteristicsn%Age, in years (median, range)164Sex Male325 Female975Total represented administrative regions763Time since diagnosis, in years (median, range)6.6711.67HbA1c (mean, 95% CI)7.961.42Receiving support from the KATIL NGO975HbA1c, glycated haemoglobin; NGO, non-governmental organisation. Descriptive characteristics of participants in qualitative interviews (n=12) HbA1c, glycated haemoglobin; NGO, non-governmental organisation. Through our qualitative analysis, participants highlighted five overarching themes: (1) barriers to care, (2) quality of care, (3) perceived control of T1D, (4) knowledge of T1D and (5) government and NGO support. A summary of these findings and their representative quotes are illustrated in table 2. Table 2Summary of findings and specific quotes organised by themeThemeSummary of findingsRepresentative quotesBarriers to careLong travel times, lack of local specialists and social stigma limited care-seeking. Financial strain from consumables. Families buy alternative glucose monitors.“It takes us 4 hours to get to Muratsan to get treatment if there is a diabetic related emergency.”“… one of my older cousins came up to me and said, ‘It’s a shame, you are such a good girl. What did you do in your past life that God punished you like this.’”Quality of careCare quality varied widely. Strong provider relationships undermined by unreliable government-provided glucose sensors.“(The doctor])makes you feel that you are completely normal”“One time, because of those strips, my child went into a coma.”Perceived control of T1DChildren report moderate self-efficacy. Frequent DKA and hypoglycaemia events.“I would probably rate it a 7, because I don’t check my sugar as often nowadays.”“I often have hypoglycemia when I sleep. I usually eat before I sleep, but I don’t eat enough for the insulin I use.”Knowledge of T1DEducation from Muratsan’s diabetes school praised. Limited knowledge prior to diagnosis.“We didn’t know it could happen in children.”Government and NGO supportGood overall coverage. Strong reliance on KATIL NGO. Government support reduces after age 18.“The government doesn’t support us after 18.”“The camp plays a huge role for us because at the camp 30 kids with diabetes come together, learn together, hang out together, and realize that they are not alone in this world.”DKA, diabetic ketoacidosis; NGO, non-governmental organisation; T1D, type 1 diabetes. Summary of findings and specific quotes organised by theme DKA, diabetic ketoacidosis; NGO, non-governmental organisation; T1D, type 1 diabetes. Barriers to care Geographical Participants from all regions outside of Yerevan commented on the lack of local paediatric endocrinologists. Inability to access local care forced families to travel long distances to reach Muratsan, with some travelling up to 4–5 hours each way. This barrier delayed access to emergency and routine care. [It] takes about 3 minutes to get to the Sisian clinic. But they can’t treat us there. It takes us 4 hours to get to Muratsan to get treatment if there is a diabetic related emergency. (Female Child, Syunik) Well now that I live in the Ararat province, it would take about 1-1.5 hours to get to Muratsan. (Male Child, forcibly displaced from Artsakh) Social stigma 11 out of 12 participants expressed that they have experienced some form of stigma related to their T1D. Their community’s perception of diabetes ranged from believing it to be a contagious disease to a shameful condition. The participants reported that these misconceptions negatively affected their social well-being. Many children highlighted the importance of educating civil society and the benefit it could have on reducing stigma. I remember, one of my older cousins came up to me and said, ‘It’s a shame, you are such a good girl. What did you do in your past life that God punished you like this.’ (Female Child, Ararat) Financial While participants received government-supplied Gmate strips, they often resorted to buying the more expensive Accu-Chek test strips given their inconsistency. The financial burden varied from ֏7000 to ֏22 000 per month (~US$18 to US$52), with some obtaining alternatives free from KATIL and others paying out of pocket. Otherwise, diabetes care was well covered under the state’s paediatric programme. All participants also expressed a desire for continuous glucose monitors (CGMs), highlighting that they would reduce the burden of finger pricking, particularly during school. Insulin supply was largely reliable, though all participants noted that collection required a trip to Yerevan due to centralised distribution. Gmate is sometimes off by 100mg/dL. That’s why we end up using the other strips. (Female Child and Caregiver, Tavush) Something we’d like to have is the freestyle sensor, especially for younger kids. They don’t know how to express when their sugar is low so it would be very helpful for them. (Female Child, Ararat) Quality of care Perception of quality was widely variable. Once registered as a patient, follow-up care was generally well-regarded, with many participants building strong relationships with staff over time. However, there were encounters with physicians that delayed care due to inaccurate clinical judgement and lack of empathy. [The doctor] is so kind and sweet that you forget all the bad things about diabetes. She makes you feel that it is completely normal. (Female child 2, Yerevan) We went to visit a doctor once, they were a different specialist (not endocrinologist), and when we mentioned our son had diabetes, he said ‘Oh my god, diabetes at this age!?’ So, when the doctor says that, you also start to worry. (Male Child and Caregiver, Shirak) 10 out of 12 participants expressed concerns over the reliability and quality of the government-supplied Gmate strips. Readings diverged significantly between fingers, leading to mismanagement and in one case a hypoglycaemic coma. As a result, multiple patients sold their allocated strips to fund better alternatives at nearly double the price. One time, because of those strips, my child went into a coma. (Caregiver 4, Yerevan) We know that there is a slight difference in measurements between each finger. But, when you measure and it is 17 mmol/L on one finger, and 11 mmol/L on the other, you start to doubt it. (Female Child, Armavir) However, two participants reported no concerns with the Gmate strips. One participant stated: The Gmate strips are okay, we haven’t noticed any issues with them. (Male Child and Caregiver, Vayots Dzor) The other participant added: “The Gmate strips are fine, but I prefer to use Accu-Chek.” (Female Child, Ararat) Perceived control of T1D Glucose control Many children stated that they were able to maintain their HbA1c around 7–8%. 8 out of 12 measured their HbA1c every 3 months, while others measured less frequently. Some identified their school schedule and changes in eating habits as hindrances to more frequent monitoring. I do pretty much a good job. I guess when I first got the diagnosis, I was really obsessed with checking my blood sugar, eating the right foods, and it was quite okay and controlled. So at first it was a 9. Then somehow, I became depressed because of all this, and I completely lost control one year ago. But now I would rate it a 7. (Female Child 2, Yerevan) Complications All children reported multiple diabetic ketoacidosis (DKA) events, with most having at least one episode a year. Most managed mild cases at home with access to intravenous therapy and ketone strips, though some required extended inpatient admissions. Most participants also described hypoglycaemic events several times per week and a single diabetic coma over their lifetime, typically around the time of their diagnosis. I have [DKA] about 2–3 times a year. We used to come all the way the Yerevan when I was younger to stay at Muratsan, but now we just deal with it at home. The doctor guides us and tells us what to do. (Male Child and Caregiver, Shirak) I often have hypoglycemia when I sleep. I usually eat before I sleep, but I don’t eat enough for the insulin I use. It happens 2–3 x per week that I wake up from my sleep because I feel hypoglycemic. (Female child 2, Yerevan) Self-assessment Apart from two children who were using CGMs, children measured their sugars at least three times a day. Participants were asked to assess control of their diabetes on a scale of 1–10, with 10 being optimal. All the answers ranged from 6 to 9. Some identified their school schedule and changes in eating habits as being hindrances to their ability to test more frequently. Several patients identified that they were able to manage their sugars better in middle school but are not as attentive now that they are in high school. I’d say it was an 8. It’s not a 10 because I don’t eat food at the same time and my classes get in the way. (Female Child, Syunik) Knowledge of T1D All children except one received diabetes education from the school at Muratsan, which offers staged classes for newly diagnosed individuals. All reported the classes to be helpful and attended multiple times. However, participants noted that the accompanying book contained outdated information, and some found its framing around incurability distressing. You know what, there was this one sentence in the book that really hurt me. I would appreciate if it was written in a nicer way, that says yes you can live a normal life, but you will have to live with diabetes. (Female child, Ararat) Prior to diagnosis, most participants had no knowledge that T1D could occur in children, which contributed to delayed recognition of symptoms. We didn’t know anything. A family member has diabetes, but they are over 50 years old. We didn’t know it could happen in children. (Caregiver 4, Yerevan) Government and NGO support Government support Participants received free monthly insulin, 100 test strips monthly until age 18, quarterly HbA1c tests (only at four centres in Yerevan), hospital stays, doctor visits and ֏39 000 (~US$100) in social support if deemed socially vulnerable (E Aghajanova, personal communication, 2025). A problem identified by all participants was the reduction in coverage once they turned 18. The government doesn’t support us after 18. You see, we don’t get insurance after 18 because the government says that diabetes is not that kind of a big deal to have insurance for it. (Female Child 2, Yerevan) NGO Support All participants expressed their gratitude to the services KATIL offers. The summer camp was a highlight for the children, where they were able to meet others with T1D and create friendships. Both the camp and other social events hosted by KATIL have led to the development of a vibrant T1D community that participants continually referenced throughout the interviews. Many participants received test strips or CGMs from KATIL. I am so thankful for KATIL. There are so many families that are grateful for KATIL and Karine [Director of KATIL]. She does so much for us. She is so attentive to every single child. From diabetes camps to everything else. Whenever I call Karine for assistance, she is always there for us and does everything she can to support us. (Female Child and Caregiver 3, Yerevan) The camp plays a huge role for us because at the camp 30 kids with diabetes come together, learn together, hang out together, and realize that they are not alone in this world. This plays a huge role on their psychological state. (Female Child, Armavir) Discussion The story that emerged from these interviews was one of resilience, adaptation and community within a healthcare system that is gradually expanding but remains constrained by geography, capacity and a legacy of centralised state provision. This study set out to elicit the lived experience of children with T1D and their caregivers in Armenia, and in doing so, surfaced challenges that are familiar to the global T1D literature and distinctly shaped by the post-Soviet context. This reflects broader patterns observed across post-Soviet health systems, where healthcare centralisation and the persistence of the dispensary model continue to shape access, delivery and patient expectations of care.10 The challenges this community described, namely long travel distances to specialist care, unreliable government-supplied consumables, dependence on civil society organisations and pervasive stigma, echoed findings from qualitative T1D studies in Liberia, Malawi, Kenya and Ghana.71416 What distinguishes the Armenian experience is not the presence of these challenges, but the form they take in a country where the expectation of comprehensive state provision runs deep.10 Understanding this context is essential to interpreting what participants said, and to understanding why community-level adaptations like selling government-supplied strips to buy better ones or relying on an NGO for T1D care emerged as responses to a system in transition. Supply chain mistrust and community expectations 10 of 12 participants expressed scepticism of government-supplied Gmate strips due to their poor quality, with many selling them to buy alternatives at double the price. This mistrust had negative reverberations in how quality of care was perceived. The community experience here reveals a disconnect between procurement practice and the country’s own endorsed standards. A 2018 accuracy study found that Gmate strips fell within 15% of the reference value only 71% of the time.19 Armenia’s national guideline on glycaemic control for children, endorsed by the Ministry of Health in 2022, cites the ISO 15197:2013 standard requiring 95% of results within 15% of the reference value.20 Participants universally also expressed a desire for CGMs, both for health benefits and to minimise the social stigma attached to finger-pricking at school. CGMs have demonstrated reductions in HbA1c and improvements in quality of life in randomised trials.21 Participants noted that KATIL began providing CGMs in limited quantities for highest-risk individuals. In doing so, this unintentionally put pressure on the formal system to provide CGMs, with some participants stating that this is the government’s responsibility. This relationship highlights the role of NGOs in transitioning systems as they can heavily influence public perception and a community’s expectations. Since the interviews, the government approved a 3-year programme to supply CGMs to all children under the age of 18 starting from January 2026 (E Aghajanova, personal communication, 2025). Deficits of a centralised system and opportunities for improvement Participants from every province outside Yerevan described a version of the same experience. Local clinics are within minutes of their homes, but specialist care required journeys of up to 5 hours each way. This reflects the Semashko system structural legacy in which specialised capacity was deliberately concentrated in the capital.10 This mirrors findings from Kenya and Malawi, where patients are required to travel long distances and restructure their lives around specialist care.14 15 What differs in Armenia is that the infrastructure for decentralisation arguably exists. 99.5% of rural households in Armenia have internet access and most healthcare facilities have computers making a strong case for telemedicine.22 Telemedicine models have demonstrated reductions in hospitalisations and improvements in subspecialist access in comparable settings.2326 Additionally, while there are no specialists outside the capital, there is a limited distribution of primary care providers that can be better used.27 Therefore, the gap is not connectivity but trained personnel and system design. KATIL has already begun filling part of this gap by providing T1D education to primary care providers, with physicians reporting improved ability to recognise and manage T1D as a result. Regarding the telemedicine transition, this is an opportune time as Armenia has taken loans from the Asian Development Bank to advance healthcare reforms that in part link disbursements to expanded telemedicine capacity.28 Anxiety with transitions in care during emerging adulthood All participants expressed anxiety about losing government coverage at 18, naming specific items that would become out-of-pocket and reflecting on what that would mean as they entered higher education or the workforce. This resonates with the international literature on emerging adulthood as a high-risk period for T1D, when competing academic, financial and social pressures drive increased complications and deteriorating glycaemic control.2931 In the Armenian context, the sharpness of these criticisms reflects an expectation of continued state provision. Its withdrawal registers as abandonment rather than a transition in their care. Since the interviews, the government has extended coverage of insulin analogues and test strips to age 28, but hospital stays and HbA1c tests remain out-of-pocket (E Aghajanova, personal communication, 2025). These changes illustrate the utility of community-informed advocacy as a mechanism for policy accountability. Civil society filling the gap 9 of 12 participants received direct support from KATIL, whether test strips, CGMs or psychosocial services. While acknowledging that this may have biased responses, the depth of affection and universal gratitude participants expressed toward KATIL was striking. Participants described KATIL’s director by name, recounted specific interventions and credited the organisation’s summer camps with giving a sense of belonging that the medical system had not provided. It was interesting to see the degree to which participants appear to put their trust in KATIL which contrasts with their lack of trust in formal institutions. In a setting where state provision historically carried the highest legitimacy, this inversion reflects how public sentiment has shifted. This pattern is not unique to Armenia, with NGOs demonstrating substantial benefits to T1D outcomes across multiple LMICs by complementing formal systems.8 32 Formalising the relationship between KATIL and the government would bring community-level knowledge, advocacy and trust into a system that could benefit from those qualities. A task force comprising government members, NGOs, healthcare providers and patient representatives would be a practical mechanism for achieving this. Stigma and community support systems 11 of 12 participants described stigma ranging from community members who believed diabetes was contagious to a physician who responded without empathy or knowledge. This affected willingness to self-monitor in public, social relationships and in at least one case, a sense that the condition was a form of punishment. This mirrors global findings on T1D-related stigma, which has been shown to increase concealment, reduce self-care and worsen glycaemic outcomes.7 14 33 34 What the community perspective adds here, beyond confirming that stigma exists, is insight into how it is being countered. Participants consistently identified KATIL’s summer camp, where 30 children with T1D spend time together, as a formative experience. The camps created friendships, normalised the condition and developed a peer community. School-based education and media campaigns have their role, but the peer community model deserves recognition as a distinct and replicable intervention.35 36 Policy implications This study demonstrated that patients are highly attuned to their needs and the deficits of the systems they interact with. These lived experiences point to five areas where community-informed reform could be realistically pursued. (1) Replace government-supplied Gmate strips with ISO 15197:2013-compliant monitors and continue providing CGMs; (2) monitor the recent extension of coverage to age 28 for effective implementation; (3) formalise the KATIL-government partnership through a dedicated task force; (4) expand local capacity through primary care provider training and telemedicine infrastructure; and (5) coordinate community-driven public awareness campaigns, addressing T1D stigma through schools and media. Limitations This study contains several limitations. Participants were limited to children aged 13–17 registered at Muratsan, meaning findings cannot be generalised to younger children, adults or those outside the formal care system. The study focused on depth of interviews rather than breadth to attain high quality interviews with participants. Although interviews spanned seven of Armenia’s ten administrative regions, three provinces were unrepresented. Recruitment through Muratsan and KATIL may have introduced a selection bias as participants likely had greater access to care and may have answered more favourably. Conducting some interviews at Muratsan may have introduced social desirability bias, with participants answering more favourably toward the hospital and its affiliated services. Conclusion T1D remains a complex condition to manage, particularly in resource-constrained settings. Qualitative studies have identified important challenges in T1D care across such settings, but these frameworks do not fully capture the structural dynamics of centrally organised health systems. This study provides insight into the lived experiences of children with T1D in Armenia, highlighting system-level challenges shaped by a post-Soviet healthcare structure. These include unreliable glucose monitoring supplies, geographical barriers to specialist care, discontinuity of support at the transition to adulthood, reliance on non-governmental organisations and persistent stigma across social and clinical environments. Together, this reflects a system in transition where provision exists but remains fragmented. These findings have relevance beyond Armenia. Health systems shaped by centralised models of care and evolving state provision, including those in post-Soviet contexts, share structural features that influence chronic disease management. In such settings, community perspectives are not supplementary; they are indispensable for identifying system-level deficiencies that are not captured through traditional data sources. Supplementary material